Molina Healthcare price target lowered to $180 from $210 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Molina Healthcare (MOH) to $180 from $210 and keeps a Neutral rating on the shares. Shifting Medicaid enrollment and tighter state budgets drive the firm’s view that program visibility remains low, leaving it “less confident” than Molina’s targeted 2.5% margin in 2026, the analyst tells investors. The firm, whose 2026 Medicaid and Marketplace outlook is more cautious than management, argues that $14 in FY26 EPS is “not fully derisked” at Molina’s level of Medicaid exposure.